INTRODUCTION
Detection of antinuclear antibodies in serum is used in the diagnostics of systemic lupus erythematosus (SLE) and other connective tissue autoimmune disorders. 1, 2 Different methods are applied for their measurement, but indirect immunofl uorescence assay (IFA) has remained the "gold standard" in ANA screening for more than 50 years. [3] [4] [5] Initially, rodent tissue samples (rat liver) were used as test substrates, but later human epithelial cell line HEp-2 and its modifi cation HEp-2000 were introduced into routine practice, increasing IFA sensitivity for ANA detection. 6, 7 McCoy-Plovdiv cell line is also used as an alternative substrate in ANA diagnostics. 8, 9 Different patterns of nuclear fl uorescence -homogenous, speckled (fi ne and coarse), centromere, nucleolar, SS-A, associated with antibodies against specifi c nuclear antigens and typical for different autoimmune disorders, are found on IFA-ANA. 9, 10 Another widely used method for ANA measurement is ELISA. It is automated, standardized, and relatively more convenient for screening great numbers of serum samples for ANA.
Specificity of ANA found with screening methods may be determined with the Farr test, counter immunoelectrophoresis, passive hemagglutination, IFA with Crithidiа lucillae for antidsDNA, ЕLISA, immunoblot (linear immune test), multiplex immunotest, fl ow cytometry, and antigen microarray. 1, 2, [11] [12] [13] The latter two techniques are still experimental, while ELISA and immunoblot are regularly used in clinical practice. Clinically signifi cant autoantibodies against dsDNA, histones, SS-A, SS-B, Sm, RNP, Jo-1, Scl-70 are specifi ed using these tests -with purifi ed nuclear extracts and recombinant antigens. 14, 15 The strategies for ANA determination differ from laboratory to laboratory. However, fi nding the most appropriate (sensitive, specifi c and economically justifi ed) combination of methods is still a subject of intensive comparative studies. No clear algorithm for ANA diagnosis is present in laboratory immunology. Hence, the aim of the current study is to determine and propose a justifi ed immunological approach for identifi cation of clinically signifi cant ANA by comparing the screening tests -ANA-IFA on serum-free McCoyPlovdiv cell line with ELISA for total ANA, and confirmative methods for specific ANA-ELISA with immunoblot.
MATERIALS AND METHODS

SERUM SAMPLES
The study included serum samples from 38 patients with suspected autoimmune disorders admitted to the Research Immunology Center at Medical University-Plovdiv and/or in the German-Bulgarian Medical Diagnostic Laboratory "Synwest-K" -Plovdiv for ANA determination. All serum samples were screened with IFA and ELISA for total ANA and the positive ones were tested with ELISA and immunoblot to determine the specifi city of detected autoantibodies.
METHODS
1. IFA-ANA. IFA-ANA (IGG) IFA-ANA. IFA-ANA (IgG) was performed on serumfree McCoy-Plovdiv cell line as substrate according to Zagorov et al. 9 The serum samples were diluted 1:40 with phosphate-buffer solution for IFA-ANA screening. Positive samples were down-titrated to 1:1280 to determine the end-point positive ANA titer. Nuclear immunofl uorescence was visually assessed by two independent experienced microscopists to avoid subjective bias in conclusion. No difference was found in the image assessment. Fluorescent signal detection was done by fl uorescent microscope (Nikon Eclipse 80i, Japan) with 400 Х magnifi cation, and the image was photographed with a digital camera Nikon DS-5 Mc, Japan and stored automatically on computer for an eventual re-inspection. The intensity of each fl uorescent image was interpreted as negative (-), weak (1+), moderate (2+), strong (3+) or very strong (4+), and the type -as homogenous, speckled, nucleolar, peripheral, SS-A. 2 To avoid reduction in the fl uorescent signal with time (the so called fl uorescence "extinguishing") determination of fl uorescence model started immediately after the completion of the immune reaction within 1-2 min per sample with inspection of at least 5 visual fi elds.
2. ELISA-ANA 2.1. ELISA Screen for total ANA (IgG) (Trinity Biotech, New York, USA) contains purifi ed antigens from nuclear extracts of HEp-2 cells -dsDNA, histones, Sm, Sm/RNP, SS-A, SS-B, Scl-70, centromeres and Jo-1. Index values < 1 were accepted as negative, and ≥ 1 as positive. 2.2 ELISA for determination of specifi c ANA (Trinity Biotech, New York, USA) contains purifi ed nuclear antigens of the specifi c type. In case of homogenous fl uorescence on IFA, the samples were tested for antibodies against dsDNA and histones, in case of speckled fl uorescence -for ANA against extractable nuclear antigens Sm, Sm/RNP, SS-A, SS-B and Scl-70, and in case of nucleolar fl uorescence -for Scl-70. 9, 13, 16 Negative values were accepted for ANA-index ≤ 0.90, borderline -between 0.91 and 1.09, and positive ≥ 1.10. ELISA Screen and ELISA for specifi c ANA were performed according to the manufacturer's instructions. The optical density of the sample was determined by an absorbance reader (TECAN SUNRISE, Austria) at 450 nm and 650 nm.
3. IMMUNOBLOT FOR ANA Nucleo-9-Line immunoblot (Orgentec Diagnostika, Germany) was applied for simultaneous detection of specifi c IgG ANA against dsDNA, nucleosomes, SS-A, SS-B, Sm, Sm/RNP, Scl-70, Jo-1 and centromeres (CENP-B). The presence of specifi c АNА was detected by scanning device with specialized software (iVision Scanware) after calibration, validation by internal serum, conjugate and cut-off controls, according to manufacturer's recommendations. The result was presented graphically, and the reaction intensity, automatically measured by the software, Multiple ANA were found in most of the positive samples. Immunoblot testing determined ANA specifi c to 1 antigen in 6 serum samples, 2 ANA types were found in 2 samples, 3 ANA types -in 4 samples and 5 ANA types -in 1 sample. ELISA for specific ANA determined 6 serum samples with 1 ANA type, 5 -with 2 specifi c ANA, and 1 sample of each -with 4, 5 or 6 different ANA.
Comparison of immunoblot and ELISA for specifi c ANA showed very good agreement in determining the anti-SS-A (k = 1.000, CI 95% 1.000÷1.000), SS-B (κ = 1.000, CI 95% 1.000÷1.000) and antidsDNA (κ = 0.825, CI 95% 0.589÷1.000), moderate for anti-Sm and anti-Sm/RNP (κ = 0.479, CI 95% 0.223÷1.000) and fair for anti-histone/nucleosomes ANA (κ = 0.303, CI 95% 0.000÷0.949) ( Table 1) . Since anti-Scl-70 autoantibodies were detected only with ELISA and were not found with immunoblot, no correspondence was present between the two methods for these antibodies.
The correlation between the type of positive ANA on ELISA and the fl uorescent pattern on IFA methods for ANA-detection stems from the great prevalence of connective tissue autoimmune disorders and the increased number of various ANA tests offered by different manufacturers. Their characteristics and features vary according to the type of included substrates, antigens and devices used. The importance of ANA as one of the basic criteria for diagnosis of SLE and other connective tissue disorders makes it essential that proper accurate, sensitive immunological tests for their determination be chosen. The three types of diagnostic methods for ANA detection (IFA, ELISA and immunoblot) we used are combined in a logical laboratory scheme (algorithm) representing a complex approach with signifi cance not only in immunology, but also in scientifi c and practical medicine in general (Fig.  2) . The combination of screening and confi rmative test for ANA offers possibility for greater range of investigation and allows fi nding of ANA against different nuclear antigens. IFA with НЕр-2 cell line is a sensitive screening method for ANA determination. 7 However, the necessity of serum addition to the medium for cellular cultivation of was proven. Homogeneous nuclear fl uorescence was found in all serum samples with presence of anti-dsDNA and anti-histone antibodies. Speckled fl uorescence was confi rmed in cases of proven extractable nuclear antigens -Sm, Sm/RNP, SS-A and SS-B. Antibodies against extractable nuclear antigens and anti-dsDNA antibodies were simultaneously found in cases of overlap of homogenous and speckled fl uorescence.
DISCUSSION
The need for research on comparability of different In the present study we found no statistically signifi cant differences between ELISA and IFA with МcCoy-Plovdiv cell substrate for determination of total ANA. However, we think IFA-ANA is superior to ELISA due to its feature of detecting different patterns of nuclear fl uorescence, directing the choice of specifi c confi rmative ELISA or immunoblot. Important advantage of IFA-ANA is the capability of fi nding antimitochondrial and other cytoplasmic antibodies, which is not possible with ELISA for total ANA. Therefore, we think that IFA-ANA is a very appropriate method for screening purposes. 3, 13 The limitation of the number of nuclear antigens in ELISA for ANA screening decreases the sensitivity of the test in comparison to IFA. In this respect Тozzoli et al. propose ANA screening with IFA. 18 Unlike them, Bayer et al. prefer ELISA. 16 Divate et al. report slightly higher sensitivity of ELISA -84.3% (at cut-off > 1.0) and 88.2% (at cut-off > 2.0) in comparison with IFA -82.4% (19) . Summarizing literature data, Kumar et al. recommend ELISA for ANA screening to be used in cases of expected medium-and high-titer ANA, because the test may fail to detect positive lowtiter ANA or some specifi c antinuclear antibodies not included in the substrate. 2 Our data on the relation between the type of fl uorescence and the specifi city of detected ANA are consistent with the results from other studies fi nding association between antibodies against extractable nuclear antigens and speckled fl uorescence on IFA, as well as between anti-dsDNA antibodies and homogenous fl uorescence. 13, 15 ELISA presents the opportunity of qualitative assessment of ANA with different specifi city, most often against dsDNA, histones, Sm, Sm/RNP, SS-A, SS-B and Scl-70. The sensitivity of the tests varies between 73% and 100%. 20 This method is expensive due to the necessity of using several ELISA for detection of ANA against the respective nuclear antigens, unlike immunoblot, by which specifi c antigens are simultaneously determined on the membrane with immobilized nuclear antigens.
According to Phan et al. immunoblot is less sensitive in detecting anti-SS-A antibodies than ELISА, for example in Sjogren syndrome sensitivity is 70-85% for immunoblot, and 90-97% for ELISА; in SLE it is 10-15% and 33-60%, respectively. 21 It is assumed that the lower sensitivity of immunoblot in anti -SS-A detection is due to "weak" transfer (blot) of SS-A antigen from the gel to the membrane, high non-specifi c background or the fact that 15% of anti-SS-A АNA recognize only conformational epitopes of SS-A 60 antigen -immunoblot, unlike ELISA, proves only linear epitopes. 21, 22 However, we found no difference between the two methods with respect to determination of these antibodies, probably because of the smaller number of investigated serum samples. Denaturation of conformational determinants after separation of antigens with polyacrylamid-gelelectrophoresis (SDS-PAGE) in immunoblot leads to greater diffi culties in fi nding ANA also against other extractable nuclear epitopes -U1 RNP, Scl-70, Sm, Jo-1. The use of blocking agents, for example detergent Tween 20, may cause renaturation of the antigen and may increase the intensity of weak strips from antigen-antibody reaction. The lower sensitivity of immunoblot for ANA against U1 RNP correlates with higher specifi city, for example in mixed connective tissue disease immunoblot specificity is 65-75%, compared to 50-60% in ELISA. The specifi city of ELISA for these ANA is increased with application of recombinant antigens. 21 Our data confi rm the lower sensitivity of immunoblot in comparison with ELISA for detection of ANA against Sm, Sm/RNP or Scl-70. 2, [21] [22] [23] We found no agreement between the two methods in detecting ANA against Scl-70, probably due to the small number of cases, but we had confi rmed these specifi c antibodies with immunoblot in other investigated serum samples.
We found anti-nucleosomal ANA with immunoblot in 5 serum samples, and anti-histone ANA with ELISA in only one. The discrepancy between these results may be attributed to the antigens included in the two methods. Immunoblot strips contain nucleosomal antigens. Each nucleosome consists of DNA and histone proteins, and ELISA is loaded only with purifi ed histone antigens. Obviously, the anti-nucleosomal antibodies direct to and react with not only histones, but also DNA, confi rmed by the fact that in all serum samples, positive for anti-nucleosomal ANA, we have also found anti-dsDNA ANA.
For the rest of the ANA (anti-dsDNA and anti-SS-B) the difference between the two methods could not reach statistical signifi cance which is similar to what has been found by other researchers. 21, 22 
CONCLUSIONS
1. The comparative study of different immunological methods for initial ANA screening found good agreement between IFA-ANA on original serum-free cells McCoy-Plovdiv and ELISA. We recommend IFA for ANA screening (compared with ELISA) because of the richer collection of nuclear and other antigens and the capacity to detect low-titer ANA. 2. ELISA and immunoblot for specifi c ANA are the fi nal stage in ANA diagnostics following a positive screening test. Despite the fact that in cases needing simultaneous detection of several specifi c ANA immunoblot is preferable compared to ELISA due to its faster and cheaper acquisition, we recommend ELISA for identifi cation of ANA against extractable nuclear antigens because of its higher sensitivity.
